USTR urges China to process biotech-corn applications in timely manner

12/17/2013 | Reuters

The Office of the United States Trade Representative is closely following issues surrounding China's rejection of U.S. corn shipments on the grounds that they included an unapproved biotech-corn variety from Syngenta. The office also encouraged the Chinese government to expedite the approval of biotech-corn varieties. "We have raised concerns with Chinese officials regarding increasing delays in the approval process for biotech events. Our expectation is that biotech approvals will be handled in a timely and predictable manner, through a transparent, science-based process," a USTR spokeswoman said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ